kynurenine mono-oxygenase inhibitors (CHDI Foundation/Evotec)

N/A

Report date: 2025/06/11 10:58:43
NME

Base Information

Drug Namekynurenine mono-oxygenase inhibitors (CHDI Foundation/Evotec)
Drug Alias NameKMO inhibitors (CHDI Foundation/Evotec)CHDI-003940246CHDI-00340246
ClassificationSmall molecules
Mechanisms of ActionKynurenine 3-monooxygenase inhibitorsNeuroprotectants
TargetsKynurenine 3-monooxygenase
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChdi Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesChdi Foundation IncEvotec SE
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A